In conclusion, we demonstrated, for the first time, that the combining use of captopril and losartan obviously attenuates the Streptococcus pneumonia-induced TS progress, probably via inhibiting the over-expression of TGF-β1. The gene discussed is TGFB1; the disease is streptococcal pneumonia.